| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.7 | 0.005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |